| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 06/26/2008 | CA2671838A1 4-imidazolines as taar's ligands |
| 06/26/2008 | CA2670839A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors |
| 06/25/2008 | EP1935892A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935886A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935881A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935421A1 Controlled-release compositions containing opioid agonist and antagonist |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1935418A1 Composition for relieving subjective symptoms of fatigue |
| 06/25/2008 | EP1935417A1 Composition for use in prevention of hypoglycemic condition |
| 06/25/2008 | EP1935416A2 Use of (Z)-2-cyano-3-Hydroxy-but-2-enoic acid-(4'-trifluorromethylphenyl)-amide for treating multiple sclerosis |
| 06/25/2008 | EP1935414A2 Carbonic anhydrase activators for enhancig learning and memory |
| 06/25/2008 | EP1935244A1 Animal model of schizophrenia |
| 06/25/2008 | EP1934227A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 06/25/2008 | EP1934223A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 06/25/2008 | EP1934222A1 Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 06/25/2008 | EP1934219A1 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| 06/25/2008 | EP1934217A1 New compounds ii |
| 06/25/2008 | EP1934216A1 Naphthyridin derivatives |
| 06/25/2008 | EP1934214A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 06/25/2008 | EP1934212A1 9-azabicyclo [3 . 3 . 1]nonane derivatives as monoamine reuptake inhibitors |
| 06/25/2008 | EP1934209A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 06/25/2008 | EP1934197A2 Duloxetine hcl polymorphs |
| 06/25/2008 | EP1934178A2 Substituted propylamine derivatives and methods of their use |
| 06/25/2008 | EP1934177A1 Prolinamide derivatives as sodium channel modulators |
| 06/25/2008 | EP1934176A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 06/25/2008 | EP1933860A2 Treatment of optic neuritis |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933831A2 Modulators of atp-binding cassette transporters |
| 06/25/2008 | EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders |
| 06/25/2008 | EP1684806B1 Compositions comprising l-type calcium channel blockers and cholinesterase inhibitors |
| 06/25/2008 | EP1675854B1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 06/25/2008 | EP1670796B1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/25/2008 | EP1377164B1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/25/2008 | EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1242822B1 Methods of detection of amyloidogenic proteins |
| 06/25/2008 | EP1200127B1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |
| 06/25/2008 | EP1033996B1 Prevention and treatment of amyloidogenic disease |
| 06/25/2008 | CN101208345A (S)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
| 06/25/2008 | CN101208344A (R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
| 06/25/2008 | CN101208340A Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 06/25/2008 | CN101208326A Derivate von dihydroxyphenylalanin |
| 06/25/2008 | CN101208324A Benzo[b]furane and benzo[b]thiophene derivatives |
| 06/25/2008 | CN101208309A Chloro-substituted guanidines |
| 06/25/2008 | CN101208304A Quinoline 3-sulfonate esters as NK3 receptor modulators |
| 06/25/2008 | CN101208294A TRPV1 agonist compounds and methods for making and using the same |
| 06/25/2008 | CN101208098A Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 06/25/2008 | CN101208095A Use of reboxetine for the treatment of pain |
| 06/25/2008 | CN101208093A Use of pyrazolyl-pyrimidine derivatives in the treatment of pain |
| 06/25/2008 | CN101208092A Methods and compositions for managing psychotic disorders |
| 06/25/2008 | CN101208015A Food composition for binding acetaldehyde in the mouth and in digestive track and method for preparation of the composition |
| 06/25/2008 | CN101205234A Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
| 06/25/2008 | CN101204576A Process for preparing cerebroprotein hydrolysate NaCl injection |
| 06/25/2008 | CN101204575A Chinese traditional medicine composite for depressive neurosis, preparation method and application thereof |
| 06/25/2008 | CN101204567A Chinese traditional medicine preparation for curing migraine |
| 06/25/2008 | CN101204550A Medicine for epilepsy |
| 06/25/2008 | CN101204534A Chinese traditional medicine capsule for healing nerve and preparing process technique thereof |
| 06/25/2008 | CN101204524A Tincture medicine for migraine |
| 06/25/2008 | CN101204515A Medicine for insomnia |
| 06/25/2008 | CN101204503A Composite of Panax notoginseng and rhizoma anemarphenae extractive |
| 06/25/2008 | CN101204434A Quality standard for thrombus dispelling pill and test method thereof |
| 06/25/2008 | CN101204433A Chinese patent medicine decoction for migraine |
| 06/25/2008 | CN101204421A Traditional Chinese traditional medicine composite for dispelling wind, activating blood circulation, stopping pain and preparation method thereof |
| 06/25/2008 | CN101204419A Tincture medicine for neurodermitis |
| 06/25/2008 | CN101204406A Prevention of damage in hippocampus of fetus/newborn infant due to maternal gestational hypertension |
| 06/25/2008 | CN101204396A Citicoline sodium dispersible tablets and preparation method thereof |
| 06/25/2008 | CN101204389A Iatric composite containing Rivastigmine and preparation method thereof |
| 06/25/2008 | CN101204380A Sustained-release coated pellets for 24 hours |
| 06/25/2008 | CN101204378A Memantine hydrochloride oral medicine compound and its preparation method |
| 06/25/2008 | CN101204281A Chinese herbs electrothermal pillow core and quilt matttress |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396673C New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/25/2008 | CN100396291C Injection of calf blood de-protein extract and preparation method thereof |
| 06/25/2008 | CN100396281C Use of rotigotine for treating the restless leg syndrome |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390922 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
| 06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
| 06/24/2008 | US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/24/2008 | US7390823 Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390812 N, N'-disubstituted piperazine compounds and their use as analgesics |
| 06/24/2008 | US7390809 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients |
| 06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
| 06/24/2008 | US7390807 Crystal forms of lamotrigine and processes for their preparations |
| 06/24/2008 | US7390802 Substituted lactams as inhibitors of Aβ protein production |
| 06/24/2008 | US7390801 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/24/2008 | US7390798 Carboxamide spirolactam CGRP receptor antagonists |
| 06/24/2008 | US7390797 Fused indazole compounds |
| 06/24/2008 | US7390785 Amino acid sequences; from venom of snails; analgesics |
| 06/24/2008 | US7390781 Methods of using truncated glial cell line-derived neurotrophic factor |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |